Corvus Pharmaceuticals: Moving Slowly Forward [Seeking Alpha]
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference